4SC AG provides results for financial year 2023 and outlook for 2024
4SC AG (4SC, FSE Prime Standard: VSC) today published its financial results for the financial year ended 31 December 202…
4SC AG (4SC, FSE Prime Standard: VSC) today published its financial results for the financial year ended 31 December 202…
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
The main challenge of the future will be to raise HVAC&R systems to an even more eco-friendly and energy-efficient level…
BITZER, the refrigeration, air conditioning and heat pump specialist, is setting new benchmarks in the operation of reci…
Espressif Systems (688018.SH), proudly announces the upcoming release of ESP32-C61, a next-generation Wi-Fi 6 + Bluetoot…
The European Medicines Agency (EMA) has granted Orphan Drug Designation for resminostat for treatment of cutaneous T…
Positive topline data for resminostat in RESMAIN pivotal study demonstrating 97.6% improvement in progression free survi…
. The European Medicines Agency (EMA) has notified 4SC that it has accepted its Letter of Intent to Submit a Marketing…
4SC AG (4SC, FSE Prime Standard: VSC) has now filed with EMA its letter of intent to file for Marketing Authorization fo…
Espressif Systems (Shanghai) Co., Ltd. (SSE: 688018.SH) is pleased to announce the availability of ESP-ZeroCode Modules…